Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;43(4):333-339.
doi: 10.1111/neup.12892. Epub 2023 Jan 15.

Midline brain hamartomatous lesions in fibrodysplasia ossificans progressiva with ACVR1 mutations

Affiliations
Review

Midline brain hamartomatous lesions in fibrodysplasia ossificans progressiva with ACVR1 mutations

Jesse Lee Kresak et al. Neuropathology. 2023 Aug.

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by extensive heterotopic ossification of soft tissue structures leading to severe limitations in movement. FOP is caused by a germline mutation in the activating receptor type IA (ACVR1) gene. Worrisome is the fact that up to a third of diffuse intrinsic pontine gliomas (DIPG) also harbor the same point mutation in ACVR1. Radiological reports of central nervous system (CNS) involvement by FOP have described brainstem masses; however, the literature on the histopathology or pathogenesis of these lesions is scant. Here we present detailed neuropathologic findings of a brainstem mass in a patient with FOP and suggest that the tumor is hamartomatous in nature. This report, along with a literature review of radiographic and laboratory data, offers support for the idea that the ACVR1 mutation may incite CNS proliferation, predominantly in the brainstem, but is probably not an oncologic driver. These lesions may be seen at autopsy and are likely noncontributory to death.

Keywords: ACVR1; brainstem; diffuse intrinsic pontine glioma; fibrodysplasia ossificans progressiva; hamartoma.

PubMed Disclaimer

Similar articles

References

REFERENCES

    1. McKusick V. #135100 FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP. Available from URL: https://www.omim.org/entry/135100. Updated August 19, 2017. [Accessed July 7, 2019].
    1. Shore EM, Feldman GJ, Xu M, Kaplan FS. The genetics of fibrodysplasia ossificans progressive. Clinic Rev Bone Miner Metab 2005; 3: 201-204.
    1. Haupt J, Deichsel A, Stange K et al. ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant. Hum Mol Genet 2014; 23: 5364-5377.
    1. Richards S, Aziz N, Bale S et al. ACMG laboratory quality assurance committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-424.
    1. Li MM, Datto M, Duncavage EJ et al. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: A joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn 2017; 19: 4-23.

MeSH terms

Substances

LinkOut - more resources